Slidenafil or Bosentan in Patients Considered Inelegible Heart Transplantation Because of Severe Pulmonary Hypertension

被引：0
|
作者：
Farrero, Maria [1 ]
Villa, Felix Perez [1 ]
Arias, Adrian [1 ]
Castel, Maria Angeles [1 ]
Sionis, Alessandro [1 ]
Roig, Eulalia [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [31] Bosentan for patients with chronic thromboembolic pulmonary hypertension
    Vassallo, Fabio Giuseppe
    Kodric, Metka
    Scarduelli, Cleante
    Harari, Sergio
    Potena, Alfredo
    Scarda, Angelo
    Piattella, Marco
    Cassandro, Roberto
    Confalonieri, Marco
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (01) : 24 - 29
  • [32] Bosentan: In pediatric patients with pulmonary arterial hypertension
    Carter N.J.
    Keating G.M.
    Pediatric Drugs, 2010, 12 (1) : 63 - 73
  • [33] Bosentan for severe pulmonary arterial hypertension: our primary experience
    Sun, Y. G.
    Yang, Z. K.
    Shi, R. F.
    Zheng, J.
    Lu, G. P.
    Shen, W. F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 : S65 - S65
  • [34] Anti-inflammatory Effects of Bosentan Therapy in Patients With Severe Pulmonary Arterial Hypertension
    Karavolias, George
    Adamopoulos, Stamatis
    Karabela, Georgia
    Gouziouta, Aggeliki
    Domproglou, George
    Georgiadou, Panagiota
    Koutrouli, Eleana
    Chaidaroglou, Antigoni
    Degiannis, Dimitrios
    Voudris, Vassilis
    CIRCULATION, 2008, 118 (18) : S878 - S878
  • [35] Transition from prostacyclin to bosentan in five patients with severe pulmonary hypertension:: The switch is possible
    Flox Camacho, Angela
    Escribano Subias, Pilar
    Tello de Meneses, Rocio
    Delgado Jimenez, Juan
    Gomez Sanchez, Miguel A.
    Saenz de la Calzada, Carlos
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (07): : 737 - 739
  • [36] EFFICACY AND SAFETY OF BOSENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION SECONDARY TO CONGENITAL HEART DISEASE
    Meng Lili
    Zhu Xianyang
    Zhang Duanzhen
    HEART, 2013, 99 : A42 - A42
  • [37] Bosentan therapy in patients with pulmonary hypertension secondary to congenital heart disease (Eisenmenger physiology)
    D'Alto, M
    Sarubbi, B
    Vizza, CD
    Romeo, E
    Santoro, G
    Argiento, P
    Russo, MG
    Calabrò, R
    CHEST, 2005, 128 (04) : 366S - 366S
  • [38] Effect of Bosentan on Pulmonary Hypertension Secondary to Systolic Heart Failure
    Padeletti, Margherita
    Caputo, Maria
    Zaca, Valerio
    Tsioulpas, Charilos
    Bernazzali, Sonia
    Mondillo, Sergio
    Maccherini, Massimo
    Jelic, Sanja
    PHARMACOLOGY, 2013, 92 (5-6) : 281 - 285
  • [39] STRUCTURE OF PULMONARY HYPERTENSION IN PATIENTS AWAITING HEART TRANSPLANTATION
    Piontek, A. A.
    Levit, A. L.
    Iofin, A. I.
    Idov, E. M.
    Klimusheva, N. F.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2009, 11 (04): : 13 - 17
  • [40] Bosentan Improves the Functional Status of Patients With Pulmonary Hypertension Due to Valvular Heart Disease
    Vlachogeorgos, Georgios
    Kourbeti, Irene
    Daskalopoulos, Nicholaos
    Blatsiotis, Panayiotis
    Mantas, Ioannis
    Stathopoulos, Georgios
    CHEST, 2013, 144 (04)
12345